rs1553572976
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_181458.4(PAX3):c.873dupC(p.Gly292ArgfsTer118) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P291P) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_181458.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
See cases Pathogenic:1
ACMG categories: PVS1,PM2,PP3,PP5 -
Waardenburg syndrome type 1 Pathogenic:1
Variant summary: PAX3 c.873dupC (p.Gly292ArgfsX118) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 251192 control chromosomes. c.873dupC has been reported in the literature in individuals affected with Waardenburg Syndrome (example: Pingault_2010). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 20127975). ClinVar contains an entry for this variant (Variation ID: 517263). Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gly292Argfs*118) in the PAX3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 188 amino acid(s) of the PAX3 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Waardenburg syndrome, type 3 (PMID: 20127975). ClinVar contains an entry for this variant (Variation ID: 517263). This variant disrupts a region of the PAX3 protein in which other variant(s) (p.Gln405Argfs*29) have been determined to be pathogenic (PMID: 9654197; internal data). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Rare genetic deafness Pathogenic:1
The p.Gly291fs variant in PAX3 has been reported in 1 individual with Waardenbur g syndrome type I (Pingault 2010). It has not been identified in large populati on studies. This variant is predicted to cause a frameshift, which alters the pr otein?s amino acid sequence beginning at position 291 and leads to a premature t ermination codon 118 amino acids downstream. This alteration is then predicted t o lead to a truncated or absent protein. Heterozygous loss of function of the PA X3 gene is an established disease mechanism in Waardenburg syndrome. In summary, this variant meets criteria to be classified as pathogenic for Waardenburg synd rome in an autosomal dominant manner based upon its predicted impact to the prot ein, presence in a previously reported affected individual, and extremely low fr equency in the general population. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at